Dr. Elizabeth Plimack on Consideration Regarding Nivolumab in RCC

Elizabeth Plimack, MD
Published: Monday, Aug 22, 2016


Elizabeth Plimack, MD, Director of Genitourinary Clinical Research, Associate Professor, department of hematology/oncology, Fox Chase Cancer Center, discusses which patients should receive nivolumab and how it and other novel agents should be sequenced in renal cell carcinoma (RCC).
 
Most RCC patients should receive nivolumab, said Plimack. Very few patients are ineligible, however those with autoimmune diseases, even if it is well-controlled, should not receive the drug.
 
Patients are living longer with RCC and therefore most will receive multiple novel agents, including nivolumab and cabozantinib, at some point during the duration of their treatment. The question of when each patient should receive which drug is still being determined, said Plimack.

Elizabeth Plimack, MD, Director of Genitourinary Clinical Research, Associate Professor, department of hematology/oncology, Fox Chase Cancer Center, discusses which patients should receive nivolumab and how it and other novel agents should be sequenced in renal cell carcinoma (RCC).
 
Most RCC patients should receive nivolumab, said Plimack. Very few patients are ineligible, however those with autoimmune diseases, even if it is well-controlled, should not receive the drug.
 
Patients are living longer with RCC and therefore most will receive multiple novel agents, including nivolumab and cabozantinib, at some point during the duration of their treatment. The question of when each patient should receive which drug is still being determined, said Plimack.

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Oncology Best Practice™: Choosing Therapies for Patients with EGFR-Mutant Lung Cancers: More Options... More Decisions... Better OutcomesFeb 28, 20182.0
Clinical Vignette Series: 34th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow®Feb 28, 20182.0
Publication Bottom Border
Border Publication
x